novomin (paziņots 2011.) kapsula
laboratorija sovremennogo zdorovja - kapsula
lenalidomide krka (previously lenalidomide krka d.d. novo mesto)
krka, d.d., novo mesto - lenalidomide hydrochloride monohydrate - multiple myeloma; myelodysplastic syndromes; lymphoma, follicular; lymphoma, mantle-cell - imūnsupresanti - multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) ir norādīts ārstēšanai pieaugušiem pacientiem ar iepriekš neārstētiem multiplā mieloma, kas nav tiesīgi transplantātu. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 un 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) ir norādīts ārstēšanai pieaugušiem pacientiem ar iepriekš neārstētiem multiplā mieloma, kas nav tiesīgi transplantātu. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 un 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).
novo vita® colostrum boost* kids (2023.) košļājamā tablete
košļājamā tablete
novo vita® astraomega+ (2023.) kapsula
kapsula
novophane (2016.) kapsula
acm laboratorie dermatologique - kapsula
ventilastin novolizer 100 mikrogrami/devā inhalācijas pulveris
meda pharma gmbh & co.kg, germany - salbutamols - inhalācijas pulveris - 100 µg/devā
fortulin novolizer 12 mikrogrami/izsmidzinājumā inhalācijas pulveris
meda pharma, sia, latvija - formoterola fumarāta dihidrāts - inhalācijas pulveris - 12 mikrogrami/izsmidzinājumā
fortulin novolizer 6 mikrogrami/izsmidzinājumā inhalācijas pulveris
meda pharma, sia, latvija - formoterola fumarāta dihidrāts - inhalācijas pulveris - 6 mikrogrami/izsmidzinājumā
naklofen 50 mg zarnās šķīstošās tabletes
krka, d.d., novo mesto, slovenia - diklofenaka nātrija sāls - zarnās šķīstošā tablete - 50 mg
naklofen 11,6 mg/g gels
krka, d.d., novo mesto, slovenia - diklofenaka dietilamīna sāls - gels - 11,6 mg/g